title: [New, in Austria registered specialty drugs. Zofran (Ondansetron, Glaxo)].
authors.affiliation: Glaxo Pharmazeutika Gesellschaft m.b.H, Wien.
authors.forename: M
authors.initials: M
authors.lastname: Erben
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000932:Antiemetics / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D001317:Austria; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D017294:Ondansetron; D011832:Radiation Injuries / Q000097:blood / Q000188:drug therapy; D014839:Vomiting / Q000097:blood / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D000932:Antiemetics; D000970:Antineoplastic Agents; D007093:Imidazoles; D017294:Ondansetron
vernacular_title: Neue, in Osterreich registrierte Spezialitäten. Zofran (Ondansetron, Glaxo).